SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Fridays selloff and the Black Monday anniversary fueled crash fears, but a sharp futures rebound prompted bulls to call the panic overblown and point to short covering and earnings; bears remained wary of a failed bounce and continued weakness in tech and AI stocks.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Q3 earnings are the central focus, with traders debating whether margins and cash flow can hold and whether managements robotaxi and AI plans justify confidence despite strong deliveries. The Roadster demo drew both praise and skepticism, but many traders say it does little to resolve concerns ahead of the results.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS is drawing attention after a sharp share-price drop amid broad biotech weakness and options-expiration volatility, while investors await the 80th-event trigger and final analysis of the Phase 3 REGAL trial of GPS. Bulls view the extended wait since the last reported event as possible evidence of longer patient survival; bears point to the delay and company silence as reasons for concern, with neither interpretation confirmed.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A sharp selloff in AI- and semiconductor-linked stocks has pressured QQQ, with traders debating whether concerns about AI spending and debt signal a broader correction or an oversold pullback. Crash warnings have been met by dip-buying and hopes for a rebound, leaving sentiment divided ahead of major tech earnings.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoins pullback and choppy trading near a closely watched support zone are driving discussion, with traders pointing to leveraged long liquidations and recent ETF outflows as signs of pressure. The community is split between expecting support to hold and a short squeeze, and warning that a breakdown could extend the decline.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trumps waiver of Russia-related sanctions and tariffs dominates discussion, with traders criticizing the move as favorable to Putin and questioning its political and market implications. Some defend it as a way to ease energy costs, while bearish comments also point to DJTs recent lows and concerns about the companys business performance.

ERock, Inc. operates, designs, and installs distributed generation power systems. The firm primarily serves data centers, utilities, commercial and industrial businesses. The company was founded on 2006 and is headquartered in Houston, TX.

ERock Inc. - Ordinary Shares - Class A

EROCs large Anthropic order and Meta-linked data-center power project are driving discussion of its growing backlog and role in supplying natural-gas microgrids amid grid constraints; bullish traders are focused on whether upcoming results show the contracts converting into revenue. Skeptics point to execution and CEO concerns, while others debate the stocks sharp swings and short interest.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

ESMO data for Iovances lifileucel-plus-Keytruda combination in first-line melanoma is driving attention, with traders highlighting response depth and durability as potential support for expanding beyond advanced melanoma. Others caution that the results come from a small cohort and may reflect an earlier data cut, so the ongoing Phase 3 TILVANCE-301 trial is seen as the key test; some also attribute the share decline to broader biotech weakness.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

IWM is drawing attention as small caps sell off amid hotter-than-expected inflation data and worries that the Fed may keep rates higher or hike again, pressuring companies sensitive to borrowing costs. Traders are debating whether oversold conditions and support levels could spark a bounce, while others cite technical breakdowns and put buying as signs of continued weakness.

Six Flags Entertainment Corp. engages in operating amusement parks in North America. It operates amusement parks, water parks, and resorts. The company is headquartered in Charlotte, NC.

Six Flags Entertainment Corp.

Six Flags Entertainment Corp

A fatal fall from a roller coaster at Six Flags Over Georgia and precautionary closures of similar rides are driving concern about safety, reputation, and potential legal exposure. Traders are divided between expecting lasting damage to attendance and the already debt-burdened company, and viewing the selloff as an overreaction; bankruptcy fears also feature prominently.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vericel Corporation (VCEL) Beats Q2 Earnings and Revenue Estimates

Vericel (VCEL) delivered earnings and revenue surprises of +200.00% and +7.58%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Vericel Stock Is Up 10%. Here's What This $402,000 Insider Sale Really Suggests

Key Points10,000 Common Stock shares were sold for a transaction value of $402,000 at an average price of around $40.24 per share on June 18, 2026...

Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More

Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More...

Vericel (VCEL) Q1 2026 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Vericel Corporation (VCEL) Reports Q1 Loss, Beats Revenue Estimates

Vericel (VCEL) delivered earnings and revenue surprises of +17.24% and +7.25%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Wall Street Analysts Think Vericel (VCEL) Could Surge 53.42%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 53.4% in Vericel (VCEL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Conestoga Capital Advisors LLC Acquires 79,278 Shares of Vericel Corporation $VCEL

Conestoga Capital Advisors LLC grew its holdings in Vericel Corporation (NASDAQ:VCEL - Free Report) by 3.6% in the fourth quarter, according to the company in its most recent 13F filing with the...

Vericel Annual Meeting: Shareholders Elect Seven Directors, Approve Say-on-Pay and PwC Auditor

Vericel (NASDAQ:VCEL) held its 2026 annual meeting of shareholders on April 29 in a virtual format, with Chairman Dr. Robert Zerbe presiding. Zerbe said the meeting was conducted pursuant to Michigan law, the company's bylaws, and the notice distributed to shareholders. Sean Flynn, Vericel's corpora...

Vericel Corporation (NASDAQ:VCEL) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Vericel Corporation (NASDAQ:VCEL - Get Free Report) have been given an average rating of "Moderate Buy" by the eight analysts that are presently covering the stock, MarketBeat.com reports...

Vericel (NASDAQ:VCEL) Shares Down 7.1% - Time to Sell?

Vericel (NASDAQ:VCEL) Trading Down 7.1% - What's Next...

Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA.

Vericel Corp

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Stocktwits

Stocktwits Polls

$VCEL I’ll take the modest gain over a pointy stick in the eye any day of the week. 
But you can confidently assume that they’re sharpening up the spears for an end of the week ocular gouging tomorrow.

$VCEL I nearly wrote the am that I’m gonna adopt a more even and positive approach on the board regarding the company.  
That did last a NY minute. 
Down… big… again.  
Sigh and WTF?

$VCEL Truist finally comes to the conclusion that their outlook for vcel was BS and drops pps targets from 58 to 52$/share. 
Sadly even rahrah supporters of this management debacle are seeing the writing on the wall… failed growth and anemic share value.  
Wonder if they got some inside dope regard the latest Q numbers.

$VCEL this market is corrupt beyond belief. Moving 70% to real estate and leaving 30% in this corrupt market for now.

Feed

News

Sentiment

Earnings

Fundamentals

Info

VCEL Vericel Corp

Fundamentals

Latest VCEL News